Exeter Financial LLC Increases Stock Holdings in Colgate-Palmolive (NYSE:CL)

Exeter Financial LLC lifted its stake in shares of Colgate-Palmolive (NYSE:CL) by 2.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,853 shares of the company’s stock after acquiring an additional 346 shares during the quarter. Exeter Financial LLC’s holdings in Colgate-Palmolive were worth $1,259,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. State Street Corp grew its holdings in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after purchasing an additional 1,784,411 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Colgate-Palmolive by 2.8% in the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock valued at $2,095,325,000 after acquiring an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in shares of Colgate-Palmolive by 6.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock worth $988,997,000 after acquiring an additional 557,492 shares in the last quarter. Legal & General Group Plc grew its stake in Colgate-Palmolive by 0.8% in the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock valued at $755,465,000 after acquiring an additional 61,413 shares during the last quarter. Finally, Barclays PLC increased its position in Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after buying an additional 2,132,747 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Activity

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Trading Up 0.8 %

CL opened at $87.02 on Tuesday. The company has a 50-day simple moving average of $92.49 and a 200 day simple moving average of $97.98. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a twelve month low of $79.69 and a twelve month high of $109.30. The stock has a market capitalization of $71.10 billion, a price-to-earnings ratio of 24.93, a P/E/G ratio of 3.31 and a beta of 0.44.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CL shares. Piper Sandler cut their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen cut their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Wells Fargo & Company reduced their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a report on Friday, October 11th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $103.63.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.